Literature DB >> 7695288

Resistance of Candida species to fluconazole.

J H Rex1, M G Rinaldi, M A Pfaller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7695288      PMCID： PMC162475          DOI： 10.1128/AAC.39.1.1

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  76 in total

1.  Emergence of oropharyngeal candidiasis caused by non-albicans species of Candida in HIV-infected patients.

Authors:  F Barchiesi; V Morbiducci; F Ancarani; G Scalise
Journal:  Eur J Epidemiol       Date:  1993-07       Impact factor: 8.082

Review 2.  Antifungal susceptibility testing.

Authors:  J H Rex; M A Pfaller; M G Rinaldi; A Polak; J N Galgiani
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

3.  Fluconazole resistance in Candida glabrata.

Authors:  C A Hitchcock; G W Pye; P F Troke; E M Johnson; D W Warnock
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

4.  Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients.

Authors:  J R Wingard; W G Merz; M G Rinaldi; C B Miller; J E Karp; R Saral
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

5.  Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1.

Authors:  M L Cameron; W A Schell; S Bruch; J A Bartlett; H A Waskin; J R Perfect
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

6.  Fluconazole-resistant Candida in AIDS patients. Report of two cases.

Authors:  G S Heinic; D A Stevens; D Greenspan; L A MacPhail; C L Dodd; S Stringari; W M Strull; H Hollander
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1993-12

7.  Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group.

Authors:  P Sandven; A Bjørneklett; A Maeland
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

8.  Fluconazole-resistant Candida albicans.

Authors:  D J Boken; S Swindells; M G Rinaldi
Journal:  Clin Infect Dis       Date:  1993-12       Impact factor: 9.079

Review 9.  Resistance of yeasts to azole-derivative antifungals.

Authors:  F C Odds
Journal:  J Antimicrob Chemother       Date:  1993-04       Impact factor: 5.790

10.  Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole.

Authors:  E Bart-Delabesse; P Boiron; A Carlotti; B Dupont
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948
View more
  234 in total

Review 1.  Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.

Authors:  M A Ghannoum; L B Rice
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

2.  Multilocus genotypes and DNA fingerprints Do not predict variation in azole resistance among clinical isolates of Candida albicans.

Authors:  L E Cowen; C Sirjusingh; R C Summerbell; S Walmsley; S Richardson; L M Kohn; J B Anderson
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

3.  Divergence in fitness and evolution of drug resistance in experimental populations of Candida albicans.

Authors:  L E Cowen; L M Kohn; J B Anderson
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

Review 4.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

5.  Genome-wide expression patterns in Saccharomyces cerevisiae: comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol.

Authors:  G F Bammert; J M Fostel
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

6.  Microbiological characteristics of yeasts isolated from urinary tracts of intensive care unit patients undergoing urinary catheterization.

Authors:  N Febré; V Silva; E A Medeiros; S B Wey; A L Colombo; O Fischman
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

Review 7.  Fungal resistance.

Authors:  H Bernhardt; K Zimmermann; M Knoke
Journal:  Infection       Date:  1999       Impact factor: 3.553

Review 8.  Strategies for the identification of virulence determinants in human pathogenic fungi.

Authors:  R Alonso-Monge; F Navarro-García; E Román; B Eisman; C Nombela; J Pla
Journal:  Curr Genet       Date:  2003-02-08       Impact factor: 3.886

Review 9.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

10.  Prospective, multicenter surveillance study of Candida glabrata: fluconazole and itraconazole susceptibility profiles in bloodstream, invasive, and colonizing strains and differences between isolates from three urban teaching hospitals in New York City (Candida Susceptibility Trends Study, 1998 to 1999).

Authors:  Amar Safdar; Vishnu Chaturvedi; Brian S Koll; Davise H Larone; David S Perlin; Donald Armstrong
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.